Study | Year | Country | Study type | Site | Total | Leak | Stricture | AGE,years | BMI,kg/m² | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CS | LS | CS | LS | CS | LS | CS | LS | CS | LS | |||||
Hirofumi Sugita | 2021 | JAPAN | retrospective | Thoracic | 30 | 30 | 1 | 1 | 5 | 2 | 72[47–87] | 72[51–87] | 24.7[18.5–30.2] | 24.7[18.5–30.2] |
Takahiro Hosoi | 2021 | JAPAN | RCT | Cervical | 42 | 53 | 3 | 4 | 18 | 0 | 70[46–81] | 66[47–82] | 21.8[15.3–29.7] | 21.1[15.8–28.0] |
Yuki Hirano | 2020 | JAPAN | retrospective | Cervical | 86 | 86 | 10 | 11 | 24 | 12 | 66 ± 8 | 65 ± 8 | 21.4 ± 2.6 | 21.4 ± 3.6 |
Zhang | 2019 | CHINA | prospective | Thoracic | 42 | 35 | 2 | 3 | 3 | 2 | 61.9 ± 7.8 | 61.4 ± 9.2 | 22.9 ± 2.2 | 22.6 ± 4.4 |
Fady Yanni | 2019 | UK | retrospective | Thoracic | 85 | 74 | 13 | 3 | 8 | 4 | 68 | 65.5 | NA | NA |
Wolfgang Schroder | 2019 | RUSSIA | retrospective | Thoracic | 427 | 109 | 135 | 14 | NA | NA | 64[57–70] | 64[57–70] | 26 [23–29] | 26[23–29] |
Jiang | 2018 | CHINA | prospective | Cervical | 164 | 34 | 14 | 3 | 31 | 1 | NA | NA | NA | NA |
Huang | 2017 | CHINA | retrospective | Cervical | 42 | 39 | 8 | 3 | 10 | 1 | 57.9 ± 8.2 | 61.0 ± 8.9 | 21.5 ± 3.5 | 22.8 ± 3.3 |
MasuzawaT | 2016 | JAPAN | retrospective | Cervical | 31 | 12 | 5 | 1 | 6 | 1 | NA | NA | NA | NA |
Benedetto Mungo | 2016 | USA | prospective | Thoracic | 38 | 12 | 4 | 2 | NA | NA | 66[63.5–72.5] | 66[63.5–72.5] | 26.9 (24.3, 26.9) | 26.9 (24.3, 26.9) |
Li | 2015 | CHINA | retrospective | MIXED | 14 | 70 | 2 | 0 | 2 | 2 | NA | NA | NA | NA |
Wang | 2013 | CHINA | RCT | Thoracic | 47 | 35 | 0 | 1 | 9 | 0 | 61.4 ± 7.7 | 59.7 ± 7.4 | NA | NA |
Theolyn N.Price | 2013 | USA | prospective | MIXED | 48 | 327 | 4 | 35 | 15 | 49 | NA | NA | NA | NA |
XU | 2011 | CHINA | prospective | Thoracic | 68 | 166 | 1 | 2 | 14 | 3 | 61.3 ± 7.6 | 60.2 ± 8.4 | NA | NA |
Shanda H. Blackmon | 2007 | USA | prospective | Cervical | 23 | 23 | 1 | 2 | 2 | 2 | 62 ± 12 | 61 ± 9 | 26 ± 5 | 26 ± 4 |
Furukawa Y | 2005 | JAPAN | retrospective | NA | 8 | 12 | 2 | 1 | 4 | 1 | NA | NA | NA | NA |